|
|
Submission Requirements
Requirements for Educational Grants
To expedite grant request processing:
- Submit your educational grant request on-line at least 60 days prior to the date of the proposed educational program/initiative. It is the requestor’s responsibility to submit application materials in a timely fashion and in consideration of the proposed date of the educational program/initiative.
- Submit only completed forms and submit all forms at once. If all forms are not submitted and/or any are incomplete, the grant request will not be reviewed
- Forms to be submitted include:
- Grant Request Form, completion of which includes requestor and program information such as a description of the activity, its educational purpose, and tax identification number
- Program Agenda, if applicable, with timing, title(s), target audience, speakers (if selected), whether CME/CE credits will be awarded, and learning objectives
- The amount of funding requested, including a budget detailing the proposed use of funds
- W-9
Requirements for Charitable Grants
To expedite grant request processing:
- Submit your educational grant request on-line at least 60 days prior to the date of the proposed educational program/initiative
- Submit only completed forms and submit all forms at once. If all forms are not submitted and/or any are incomplete, the grant request will not be reviewed
- Forms to be submitted include:
- Grant Request Form, completion of which includes requestor and program information such as a description of the activity, its purpose and tax identification number
- Mission Statement
- Program Agenda, if applicable, with timing, title(s), target audience, speakers (if selected), and learning objectives.
- The amount of funding requested, including a budget detailing the proposed use of funds
- W-9
- IRS Letter of Determination providing evidence of 501 (c)(3) tax-exempt status
Please return all Grant Request Forms and supporting documents to:
- Salix Pharmaceuticals, Inc.
- Grants Coordinator, Medical Affairs
- Fax: 888-314-5934
- E-mail:
Confirmation and Notification
- An e-mail will be sent to confirm receipt of the grant request
- Salix's grant committee review process will take approximately 4-6 weeks
- Once the review process is complete, a notification with the decision will be sent
- If approved, a Salix-signed Letter of Agreement will be sent
- Authorized person/organization will receive the grant payment within 4 weeks of approval
Budget Guidelines
- Grant requests must include a reasonable and comprehensive budget outlining the cost of grant-funded activities
- Grants may be issued to support only the costs associated with the development, delivery or evaluation of the educational program, resources, or materials
- Grants may not cover costs that are neither reasonable nor customary
COLAZAL® (balsalazide disodium) Capsules 750 mg are indicated for the treatment of mildly to moderately active Ulcerative Colitis in patients 5 years of age and older.
COLAZAL does not relieve symptoms in all patients; your patients' results may vary. In four well-controlled clinical trials, patients receiving a COLAZAL dose of 6.75g/day most frequently reported the following events
(reporting frequency > 3%): headache (8%), abdominal pain (6%), diarrhea (5%), nausea (5%), vomiting (4%), respiratory infection (4%), and arthralgia (4%). Withdrawal from therapy due to adverse events was comparable to
placebo. In the pediatric trial, patients most frequently reported the following adverse events: headache (15%), abdominal pain upper (13%), abdominal pain (12%), vomiting (10%), diarrhea (9%), colitis ulcerative (6%),
nasopharyngitis (6%) and, pyrexia (6%). COLAZAL is contraindicated in patients with a hypersensitivity to salicylates or the components of COLAZAL capsules or balsalazide metabolites. The safety and effectiveness of
COLAZAL beyond 8 weeks in children (ages 5-17 years) and 12 weeks in adults have not been established.
Consult with your physician to see if this product is right for you.
For complete Prescribing Information, please click here.
|
|